Skip to content

Clinical trials

Phase 3 Uveitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uveitis Phase: Phase 3 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20091
20105
20111
20122
20131
20142
20152
20172
20192
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated9
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
XOMA (US) LLC4
JHSPH Center for Clinical Trials3
Lux Biosciences, Inc.3
Clearside Biomedical, Inc.2
Duke University1
EyePoint Pharmaceuticals, Inc.1
National Eye Institute (NEI)1
Novartis1
Priovant Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uveitis26
Uveitis, Intermediate15
Uveitis, Posterior15
Panuveitis13
Uveitis, Anterior4
Arthritis, Juvenile2
Behcet Syndrome2
Macular Edema2
Arthritis1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.